Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-25 @ 11:17 PM
Study NCT ID:
NCT00160693
Status:
COMPLETED
Last Update Posted:
2018-08-01
First Post:
2005-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis
Sponsor:
UCB Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
None
Study First Post Date:
2005-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-15
Results First Submit QC Date:
None
Results First Post Date:
2012-07-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-04
Last Update Post Date:
2018-08-01
Last Update Post Date Type:
ACTUAL